Stryker Universal Midface and Upper-Face Fixation System: A Retrospective Post Market Follow Up
UMF
1 other identifier
observational
150
1 country
1
Brief Summary
A retrospective post-market clinical follow-up to confirm the performance and safety of the Upper-Face and Mid-Face modules of the Stryker Universal CMF System in a clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2025
CompletedFirst Submitted
Initial submission to the registry
August 7, 2025
CompletedFirst Posted
Study publicly available on registry
November 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 27, 2026
CompletedApril 22, 2026
April 1, 2026
12 months
August 7, 2025
April 21, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Successful stabilization and/or fixation of bony segments without the need for unplanned revision surgery
Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.
Data collected at a single time point per patient in the course of 12 months.
Secondary Outcomes (7)
Intraoperative complications
Data collected at a single time point per patient in the course of 12 months.
Postoperative complications
Data collected at time points per patient in the course of 12 months.
Any known adverse events potentially related to the primary outcome objective and/or device
Data collected at time points per patient in the course of 12 months.
Implant failure
Data collected at time points point per patient in the course of 12 months.
Operating room (OR) time
Data collected at a single time point per patient in the course of 12 months.
- +2 more secondary outcomes
Other Outcomes (18)
Age
Data collected at a single time point per patient in the course of 12 months.
Primary indication for the surgery / diagnosis
Data collected at a single time point per patient in the course of 12 months.
Surgical approach/access
Data collected at a single time point per patient in the course of 12 months.
- +15 more other outcomes
Interventions
The Universal CMF System is a plate and screw system intended for osteotomy, stabilization, and rigid fixation of CMF fractures and reconstruction. Depending on the selected module, the design of the devices is more suitable for specific indications within the broad indication of CMF fractures and CMF reconstructive surgeries.
Eligibility Criteria
Eligible patients will be identified as having had a surgical procedure involving the Subject Device.
You may qualify if:
- Skeletally mature patients at the time of surgery.
- Patients who underwent a craniomaxillofacial procedure using implants of the Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of the Stryker Universal CMF System as per routine clinical practice.
- Patients for whom data on the primary outcome variable is available.
- Patients with data available from follow-up visits.
You may not qualify if:
- Patients with active infections at the time of surgery.
- Patients with known metal allergies and/or foreign body sensitivity at the time of surgery.
- Subjects with non-reducible and unstable fractures (except reconstruction plates) at the time of surgery that were treated with the subject devices.
- Patients who underwent secondary reconstructions with non-secondary reconstruction plates
- Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Weill Cornell Medicine Oral and Maxillofacial Surgery 525 East 68th Street, F-2132
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2025
First Posted
November 24, 2025
Study Start
March 28, 2025
Primary Completion
March 27, 2026
Study Completion
March 27, 2026
Last Updated
April 22, 2026
Record last verified: 2026-04